בורטזומיב טבע 3.5 מ"ג - Bortezomib teva 3.5 mg

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

××× ×× ×× × ××¡×¤××

×§×××¦× ×¤×¨××§××××××ª (ATC4)

L01XX
Other antineoplastic agents

××¨××× ×¤×¢×× (ATC5)

Bortezomib 3.5MG âL01XX32

×¦××¨×ª ××ª×

×ª××-××¨××× - I.V

×¦××¨×ª ××× ××

×××§× ×××× ×ª ×ª×××¡× ×××¨××§×, POWDER FOR SOLUTION FOR INJECTION
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Bortezomib Teva is indicated for the treatment of patients with multiple myeloma. Bortezomib Teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Bortezomib Teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation

× ×ª×× × ××¡×

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××	××¡××¡ ××××××ª
××××××× × ×¤××¦× - ××¡×¨×ª ×××××××ª ×¢× ××¡××¨×ª ×××××× ××¡×	23/01/2011	×××××××××	BORTEZOMIB	××××××× × ×¤××¦×, multiple myeloma	×¦× ××××× ××¨××××ª ×××××ª× (×ª×¨××¤××ª ××¡× ×©××¨××ª× ×××¨××××ª) ×¡×¢××£ 2× (30)
××××××× × ×¤××¦× - ×××¤×× ××©×××× ×¢× Thalidomide	03/01/2010	×××××××××	BORTEZOMIB	××××××× × ×¤××¦×, multiple myeloma	×¦× ××××× ××¨××××ª ×××××ª× (×ª×¨××¤××ª ××¡× ×©××¨××ª× ×××¨××××ª) ×¡×¢××£ 2× (30)
××××¤××× ××¡×× Mantle cell - ×××¤×× ××ª×§××	03/01/2010	×××××××××	BORTEZOMIB	mantle cell lymphoma, ××××¤××× ××¡×× mantle cell, MCL	×¦× ××××× ××¨××××ª ×××××ª× (×ª×¨××¤××ª ××¡× ×©××¨××ª× ×××¨××××ª) ×¡×¢××£ 2× (30)
××××××× × ×¤××¦× - ×§× ×××¤×× ×¨××©×× ×××××× ××¡××××× ×××× ××××:Â ×××× ××¨×××ª ××¤××©××ª ×× ×¡×¤××§×ª ×××××ª plasma cell leukemia.	01/01/2009	×××××××××	BORTEZOMIB	××××××× × ×¤××¦×, multiple myeloma	×¦× ××××× ××¨××××ª ×××××ª× (×ª×¨××¤××ª ××¡× ×©××¨××ª× ×××¨××××ª) ×¡×¢××£ 2× (30)
××××××× × ×¤××¦× - ×§× ×××¤×× ×©× × ×× ×©×××©×	01/07/2006	×××××××××	BORTEZOMIB	××××××× × ×¤××¦×, multiple myeloma	×¦× ××××× ××¨××××ª ×××××ª× (×ª×¨××¤××ª ××¡× ×©××¨××ª× ×××¨××××ª) ×¡×¢××£ 2× (30)

×©××××© ××¡×

×ª××¨×× ××××× ××¡×

01/07/2006

××¡××¨×ª ××××× ××¡×

×. ××ª×¨××¤× ×ª×× ×ª× ××××¤×× ×××§×¨×× ××××:

1. ××××××× × ×¤××¦×, ×¢×××× ×× ××ª×§×××ª ××××¨ ×××¤×× ×§××× ××× ××¤×××ª ××× ××§× ×××¤××× ×¨××©××. ×××× ×××× ×××× ××××¤×× ××ª×¨××¤× ×× ×× ××××ª× × ×©× ×ª× ××××¨ ×××¤×× ×§××× ××ª×¨××¤× ××.

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¨××¤× 31.07.2017

×¢××× ××¦×¨××	Â

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×××¨××××××× ×××¢ 3.5 ×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY
×©× ××¢× ××¨××©××	ABIC MARKETING LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 6/2014. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××

השינוי האחרון נעשה בֹ־4 בפברואר 2022 ב־15:01

בורטזומיב טבע 3.5 מ"ג - Bortezomib teva 3.5 mg

ויקיתרופות